Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Autoimmunity"
DOI: 10.1016/j.jaut.2020.102511
Abstract: Abstract In cases of COVID-19 acute respiratory distress syndrome, an excessive host inflammatory response has been reported, with elevated serum interleukin-6 levels. In this multicenter retrospective cohort study we included adult patients with COVID-19, need… read more here.
Keywords: intravenous tocilizumab; distress syndrome; acute respiratory; invasive ventilation ... See more keywords